IN8BIO, INC. Investment Income, Interest
IN8BIO, INC. (INAB) reported Investment Income, Interest of $154.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- IN8BIO, INC. investment income, interest for the quarter ending 2026-06-30 was $154.00K, a 43.93% increase year-over-year.
- IN8BIO, INC. investment income, interest for the quarter ending 2026-03-31 was $176.00K, a 60.00% increase year-over-year.
- IN8BIO, INC. investment income, interest for the quarter ending 2025-12-31 was $91.00K, a 42.19% increase year-over-year.
- IN8BIO, INC. investment income, interest for the quarter ending 2025-09-30 was $113.00K, a 391.30% increase year-over-year.
- IN8BIO, INC. investment income, interest for fiscal 2025 was $421.00K, a 83.04% increase from fiscal 2024.
- IN8BIO, INC. investment income, interest for fiscal 2024 was $230.00K.
- IN8BIO, INC. investment income, interest for fiscal 2023 was $0.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $154.00K 10-Q · filed 2026-08-06 | $330.00K 10-Q · filed 2026-08-06 | $421.00K derived: sum of 3 quarters · filed 2026-08-06 | $534.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $176.00K 10-Q · filed 2026-05-07 | $267.00K derived: sum of 2 quarters · filed 2026-05-07 | $380.00K derived: sum of 3 quarters · filed 2026-05-07 | $487.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $204.00K derived: sum of 2 quarters · filed 2026-03-12 | $311.00K derived: sum of 3 quarters · filed 2026-08-06 | $421.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $113.00K 10-Q · filed 2025-11-06 | $220.00K derived: sum of 2 quarters · filed 2026-08-06 | $330.00K 10-Q · filed 2025-11-06 | $394.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $107.00K 10-Q · filed 2026-08-06 | $217.00K 10-Q · filed 2026-08-06 | $281.00K derived: sum of 3 quarters · filed 2026-08-06 | $304.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-07 | $174.00K derived: sum of 2 quarters · filed 2026-05-07 | $197.00K derived: sum of 3 quarters · filed 2026-05-07 | $257.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $87.00K derived: sum of 2 quarters · filed 2026-03-12 | $147.00K derived: sum of 3 quarters · filed 2026-03-12 | $230.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $23.00K 10-Q · filed 2025-11-06 | $83.00K derived: sum of 2 quarters · filed 2025-11-06 | $166.00K 10-Q · filed 2025-11-06 | $166.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $60.00K 10-Q · filed 2025-08-07 | $143.00K 10-Q · filed 2025-08-07 | $143.00K derived: sum of 3 quarters · filed 2025-08-07 | $143.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $83.00K 10-Q · filed 2025-05-07 | $83.00K derived: sum of 2 quarters · filed 2025-05-07 | $83.00K derived: sum of 3 quarters · filed 2025-05-07 | $83.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |